Pregabalin
- Product NDC
- 71610-845
- Requested package NDC
- 71610-845-70
- 11-digit product format
- 716100845
- Labeler code
- 71610
- Product ID
- 71610-845_076a2ad0-6afe-43d8-a6fe-7058acc4ea92
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pregabalin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA209357
- Marketing category
- ANDA
- Marketing start
- 2019-07-19
- Substance
- PREGABALIN
- Active strength
- 150 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209357-001 | PREGABALIN | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-002 | PREGABALIN | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-003 | PREGABALIN | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-004 | PREGABALIN | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-005 | PREGABALIN | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-006 | PREGABALIN | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-007 | PREGABALIN | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | |
| A209357-008 | PREGABALIN | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209357-001 | AB |
| A209357-002 | AB |
| A209357-003 | AB |
| A209357-004 | AB |
| A209357-005 | AB |
| A209357-006 | AB |
| A209357-007 | AB |
| A209357-008 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A209357-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A209357-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A209357-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209357-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209357-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-001 | PREGABALIN | 25MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-002 | PREGABALIN | 50MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-003 | PREGABALIN | 75MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-004 | PREGABALIN | 100MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-005 | PREGABALIN | 150MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-006 | PREGABALIN | 200MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-007 | PREGABALIN | 225MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-008 | PREGABALIN | 300MG | CAPSULE / ORAL | AB | 2019-07-19 | 011fe1cb6892… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A209357-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-004 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-005 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-006 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-007 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A209357-008 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-004 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-005 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-006 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-007 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A209357-008 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-005 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-006 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-007 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209357-008 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209357-008 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-006 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209357-008 | AB | 1 | 011fe1cb6892… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pregabalin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PREGABALIN | 150 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 55JG375S6M | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 483440 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8bb9495e-1354-4a70-baa5-9b80eb3518c8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 441d8579-bd15-4585-93f4-9de3db2d851d | Product name | 4 | 20251114 |
| 004d1029-ec13-fc89-74f4-3907cf5b6602 | Product name | 2 | 20140523 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71610-845-30 | Pregabalin | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 71610-845-46 | Pregabalin | 56 in 1 BOTTLE | CAPSULE | 56 | 1 | |
| 71610-845-53 | Pregabalin | 60 in 1 BOTTLE | CAPSULE | 60 | 1 | |
| 71610-845-54 | Pregabalin | 84 in 1 BOTTLE | CAPSULE | 84 | 1 | |
| 71610-845-70 | Pregabalin | 120 in 1 BOTTLE | CAPSULE | 120 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-845-30 | EA - Each | 71610-845 | 09cd4bf9-2594-41ad-8270-497230c1b69b | 1 | 2024-09-09 |
| 71610-845-46 | EA - Each | 71610-845 | 410e9a87-b5fe-4a02-b306-69dcde7fbbd2 | 1 | 2024-09-09 |
| 71610-845-53 | EA - Each | 71610-845 | ce7bfc52-b73c-4d66-a04f-ae33fe2f0086 | 1 | 2024-09-09 |
| 71610-845-54 | EA - Each | 71610-845 | 8b0990c3-ec22-4a10-ae7b-76d40444b1a5 | 1 | 2024-09-09 |
| 71610-845-70 | EA - Each | 71610-845 | 80051374-cbba-4964-81af-52c52f1c0ddb | 1 | 2024-09-09 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin | PREGABALIN | Proficient Rx LP | 580955ba-86f6-4e86-b0fa-dd44e8828b0e | 2025-03-01 | Warnings, Adverse reactions | 209357 ANDA209357 |
| Pregabalin | PREGABALIN | Advanced Rx of Tennessee, LLC | afd59273-75d1-5f33-e053-2995a90ab25f | 2024-12-31 | Warnings, Adverse reactions | 209357 ANDA209357 |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 8bb9495e-1354-4a70-baa5-9b80eb3518c8 | 2024-07-28 | Warnings, Adverse reactions | 209357 ANDA209357 71610-845-70 71610-845 71610084570 |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | 4ed3e73c-13e7-4646-874d-276b6c75d2c9 | 2024-02-08 | Warnings, Adverse reactions | 209357 ANDA209357 |
| Pregabalin | PREGABALIN | Aphena Pharma Solutions - Tennessee, LLC | d2a98872-1a52-47e1-b4bd-0ff7d6272a92 | 2023-12-01 | Warnings, Adverse reactions | 209357 ANDA209357 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 483440 | pregabalin 150 MG Oral Capsule | PSN | 8bb9495e-1354-4a70-baa5-9b80eb3518c8 | 1 |
| 483440 | pregabalin 150 MG Oral Capsule | SCD | 8bb9495e-1354-4a70-baa5-9b80eb3518c8 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71610-845-70 | 71610084570 | 120 CAPSULE in 1 BOTTLE (71610-845-70) | 120 capsule | 2024-07-16 | No | No | Current |